Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
107,809,066
-
Total 13F shares
-
14,055,535
-
Share change
-
+13,976,857
-
Total reported value
-
$300,085,720
-
Price per share
-
$21.35
-
Number of holders
-
61
-
Value change
-
+$298,405,720
-
Number of buys
-
59
-
Number of sells
-
1
Institutional Holders of Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA) as of Q2 2016
As of 30 Jun 2016,
Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA) was held by
61 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,055,535 shares.
The largest 10 holders included
FMR LLC, ORBIMED ADVISORS LLC, BAKER BROS. ADVISORS LP, Temasek Holdings (Private) Ltd, Foresite Capital Management III, LLC, BlackRock Advisors LLC, VANGUARD GROUP INC, EcoR1 Capital, LLC, MORGAN STANLEY, and FRANKLIN RESOURCES INC.
This page lists
61
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.